Covidien updates on medical device, pharma split

February 4, 2013 by MassDevice staff

Covidien makes progress on its long-anticipated split into separate medical device and pharmaceutical businesses, incorporating the Mallinckrodt drug company in Ireland.

Covidien logo

Healthcare giant Covidien (NYSE:COV) issued updates on its long-awaited split into separate medical device and drug units and incorporated the Mallinckrodt pharmaceutical division as an independent entity in Ireland.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.